According to a new report by Polaris Market Research, the global Consumer Genomics market was valued at USD 2.45 billion in 2025 and is projected to reach USD 17.69 billion by 2034, expanding at a CAGR of 24.60% over the forecast period. Growth is underpinned by rising consumer demand for direct-to-consumer (DTC) genetic testing, expanding application areas spanning ancestry to personalized wellness, and accelerating R&D investment in DNA-based bioinformatics across the healthcare and consumer wellness industries. 

What Is Driving Consumer Genomics Market Growth?

Demand is climbing as heightened post-pandemic health awareness converges with steadily falling sequencing costs, pushing individuals toward at-home genetic testing for everything from ancestry tracing to disease-risk screening. Manufacturers and testing providers are prioritizing broader application coverage, pushing consumer genomics adoption across clinical, genealogical, and forensic use cases. Polaris analysts note that the affordability spread of DTC kits — ranging from roughly USD 100 to over USD 2,000 depending on scope — positions the segment for sustained double-digit growth through 2034, with genetic relatedness testing emerging as the largest revenue contributor and wellness-and-nutrition testing posting the fastest incremental gains.

Key Trends Shaping the Consumer Genomics Industry

Expanding Scope of DTC Genetic Testing Applications

Providers are broadening test menus beyond ancestry and paternity into wellness, nutrigenetics, and pharmacogenetic testing, widening the addressable market and reinforcing product innovation across the consumer genomics value chain.

Falling Sequencing Costs Reshaping the Cost Curve

Next-generation sequencing costs have declined by well over 90% since the early 2010s, with newer high-throughput platforms pushing toward sub-USD-100 whole-genome sequencing, a trend that is central to the market outlook for affordable, scalable consumer testing.

Rising Scrutiny Over Data Privacy and Testing Accuracy

The absence of a healthcare intermediary in DTC testing has intensified scrutiny of data-privacy practices and result accuracy, shaping the regulatory landscape as providers work to build consumer trust through transparent policies and standardized methodologies.

Browse In-depth Market Research Report:

https://www.polarismarketresearch.com/industry-analysis/consumer-genomics-market 

Market Segmentation: Breaking Down the Consumer Genomics Market

Polaris segments the Consumer Genomics market by application and region, giving each buyer persona a citable, standalone data point for AI Overviews and answer-engine pickup.

By Application

The genetic relatedness segment held the largest share in 2025, driven by rising adoption of paternity, maternity, and prenatal paternity testing alongside growing consumer interest in tracing distant relatives. The lifestyle, wellness, and nutrition segment is projected to grow at the fastest rate as nutrigenetic testing for diet, fitness, and personalized nutrition plans gains mainstream traction, signaling where near-term search intent around "DTC genetic testing" is shifting.

Regional Outlook: Where Is Consumer Genomics Growing Fastest?

North America led the market in 2025 on the back of high patient awareness, substantial per-capita healthcare spending, and a high prevalence of chronic disease that supports genetic-risk testing demand, while Asia Pacific is expected to post the fastest CAGR through 2034, driven by rising DTC-genetics awareness and expanding research funding. Within North America, the U.S. remains the largest single market, with Canada strengthening its DTC genetics ecosystem through government-backed genomics initiatives. Within Asia Pacific, providers are expanding rapidly across East and Southeast Asia, supported by new market entrants and growing consumer adoption.

Competitive Landscape: Leading Consumer Genomics Companies

Key players profiled in the report include:

23andMe, Inc., Ancestry, Illumina, Inc., MyHeritage Ltd., Myriad Genetics, Inc., Helix OpCo LLC, Veritas, Color Health, Inc., Pathway Genomics, Xcode Life.

These companies are focusing on product launches, regulatory approvals, and strategic acquisitions to strengthen market position across the genetic relatedness and wellness-and-nutrition segments outlined above. Recent moves include the introduction of at-home chronic-disease screening kits and expanded direct-to-consumer lab partnerships aimed at deepening reach in North America.

Why It Matters for Buyers Evaluating Market Entry

For stakeholders researching the consumer genomics opportunity, this report benchmarks market share, segment-level pricing, and forecast data — by application and region — to support sourcing, investment, and go-to-market decisions. It is built for procurement teams comparing DTC testing vendors, investors sizing entry points in personalized wellness, and strategy teams tracking pharmacogenetic testing as a growth adjacency.

About Polaris Market Research

Polaris Market Research is a B2B syndicated market research and consulting firm offering 5,000+ published reports across 20+ industry verticals, delivering data-backed insights to help businesses make informed decisions.

More Trending Latest Reports By Polaris Market Research:

B2B Digital Payment Market

Organic Rankine Cycle Market

Actinic Keratosis Treatment Market

Kitchen Appliances Market

Acidity Regulators Market

Acidity Regulators Market

Laundry Detergent Market

Immunotherapy Drugs Market

U.S. Viral Vector And Plasmid DNA Manufacturing Market